Unison Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 55 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with TMDA (TZ), ARCSA (EC) and CDSCO (India). Its GMP standing is certified by CDSCO (India), EMA and EAEU_EEC, among 5 authorities. Customs aggregates show $25.3M of exports covering 979 molecules to 35 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Ahmedabad, India | Not on file |
| Moraiya, India | Not on file |
| Ahmedabad, India | Not on file |
| tal sanandmoraiya 382 213ahmedabad, India | Not on file |
| ahmedabad 382 213, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| TMDA (TZ) | 22 | 1 |
| ARCSA (EC) | 13 | None |
| CDSCO (India) | 6 | 3 |
| NAFDAC (NG) | 5 | 1 |
| UZPHARM (UZ) | 4 | None |
| INVIMA (CO) | 3 | None |
| EMA | None | 2 |
| EAEU_EEC | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $5.1M | 18 |
| 2025 | Not reported | $25.3M | 35 |
| 2024 | Not reported | $20.1M | 31 |
| 2023 | Not reported | $14.4M | 21 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Unison Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.